Visual and Patient Reported Outcomes With Clareon TruPlus
Part of paid clinical trials in Saint Louis Park, Minnesota.
- Sponsor
- OVO LASIK + Lens
- Study ID
- NCT07648355
- Status
- Recruiting
Conditions
- Cataract
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Clareon TruPlus — DEVICEClareon TruPlus
Study Details
This is a prospective, single-site, two-surgeon, single-arm, observational study evaluating the Clareon TruPlus IOL. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the IOLSAT Questionnaire.
Key Dates
- Start date
- Jun 2, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 11, 2027
- Completion
- Jul 11, 2027
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Clareon TruPlus
Primary Outcome Measure
Binocular photopic DCIVA [ Time Frame: 3 months postoperatively ]
Central Contacts
- Ashley Prepeluh952-204-5060
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ovo Lasik + Lens | Saint Louis Park | Minnesota | 55416 | Martha F Whiting, MD (PRINCIPAL_INVESTIGATOR) Mark C Lobanoff, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Saint Louis Park, MN
By research site
Related Studies
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · Recruiting · Melt Pharmaceuticals · Chico, California
- Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix ProEnrolling By Invitation · Brian Shafer · Baltimore, Maryland
- Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence TomographyRecruiting · Oregon Health and Science University · Portland, Oregon
- Intraoperative OCT Guidance of Intraocular Surgery IIRecruiting · Duke University · Durham, North Carolina